6.73Open5.69Pre Close1 Volume123 Open Interest57.00Strike Price673.00Turnover109.52%IV-0.02%PremiumDec 6, 2024Expiry Date6.74Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9133Delta0.0355Gamma7.28Leverage Ratio-0.1190Theta-0.0029Rho-6.65Eff Leverage0.0065Vega
Viking Therapeutics Stock Discussion
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
lets gooooooo
No comment yet